VivoSeq
Other

Sinus Surgery

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Sinus Surgery is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

27/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

22

clinical trials

Completed12 · 55%
Withdrawn4 · 18%
Unknown status3 · 14%
Terminated2 · 9%
Not yet recruiting1 · 5%

Trial Activity

22 trials

Pain Control Following Sinus Surgery
Completed·SStanford University·Phase 4·NCT03783702·118 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)